Abstract:
The herein developed chemoproteomic isoDTB-ABPP platform streamlines the identification of binding sites of covalent ligands across bacterial proteomes, providing starting points for the development of novel antibiotics. Moreover, the described advances in the profiling of nucleophilic amino acids other than cysteine will help to expand the target space of covalent ligands and thus foster the development of antibiotics with new modes-of-action.